Company news

HOB Biotech Group Corp., Ltd. news in 2025

HOB Biotech Group Corp., Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025

November 14, 2025

Q3 2025 Continuous Supervision Opinions of China International Capital Corporation Limited on Shuangrun Zhengan Information Consulting (Beijing) Co., Ltd.'s Tender Offer to Acquire Jiangsu HOB Biotech Group Co., Ltd.

November 12, 2025

Announcement on Convening the Q3 2025 Performance Briefing

November 6, 2025

Announcement on Resolutions of the 22nd Meeting of the 3rd Board of Supervisors

October 29, 2025

Announcement on Voluntary Disclosure of Signing of Cooperation Framework Agreement and Risk Disclosure

October 21, 2025

Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025

September 25, 2025

Announcement on Progress in Voluntary Disclosure of Phase III Clinical Trial of MM09 Sublingual Spray for Allergy Immunotherapy Completes Enrollment of First Subjects Along with New Business

September 24, 2025

Announcement on Purchasing Liability Insurance for Directors, Supervisors, and Senior Management Members

September 9, 2025

Announcement on Completion of Some Investment Projects Financed by Raised Funds

September 2, 2025

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025

September 1, 2025

Q2 2025 Continuous Supervision Opinions of China International Capital Corporation Limited on Shuangrun Zhengan Information Consulting (Beijing) Co., Ltd.'s Tender Offer to Acquire Jiangsu HOB Biotech Group Co., Ltd.

August 25, 2025

Announcement on Convening the 2025 Semi-annual Performance Briefing

August 21, 2025

Announcement on Resolutions of the 19th Meeting of the 3rd Board of Supervisors

August 14, 2025

Announcement on the Sale of Land Use Rights and Plant Buildings

August 4, 2025

Announcement on Vesting Results in the 1st Vesting Period for Category II Incentive Objects of Those Initially Granted in the 2023 Restricted Stock Incentive Plan and Stock Listing Announcement

June 30, 2025

Announcement on Abnormal Fluctuations in Stock Trading

June 12, 2025

Announcement on Resolution of the 18th Meeting of the 3rd Board of Supervisors

June 11, 2025

Announcement on Convening the Q1 2025 Performance Briefing

May 28, 2025

Announcement on Implementation of Dividend Distribution for 2024

May 22, 2025

Announcement on Reply to Letter of Regulation on Information Disclosure of 2024 Annual Report

May 13, 2025

Q1 2025 Continuous Supervision Opinions of China International Capital Corporation Limited on Shuangrun Zhengan Information Consulting (Beijing) Co., Ltd.'s Tender Offer to Acquire Jiangsu HOB Biotech Group Co., Ltd.

May 12, 2025

Announcement on Resolution of the 1st Extraordinary General Meeting in 2025

May 7, 2025

Report for Q1 2025

April 28, 2025

Announcement on Resignation of Some Directors and Senior Management Members and the By-election of Non-independent Directors

April 16, 2025

Announcement on Meeting the Vesting Conditions in the 1st Vesting Period for Category II Incentive Objects of Those Initially Granted in the 2023 Restricted Stock Incentive Plan

April 9, 2025

Announcement on Resolutions of the 2024 Annual General Meeting

April 7, 2025

Announcement on Change of Financial Advisor in Charge for Continuous Supervision of the Tender Offer by Shuangrun Zheng'an Information Consulting (Beijing) Co., Ltd. to Acquire the Company's Shares

March 28, 2025

Announcement on Resolution of the 18th Meeting of the 3rd Board of Directors

March 17, 2025

Announcement on Preliminary Earnings Estimate for 2024

February 26, 2025

Announcement on Voluntary Disclosure of Wholly-Owned Subsidiaries Obtaining Medical Device Registration Certificates

February 24, 2025

Announcement on the Completion of the Tender Offer by Shuangrun Zheng'an Information Consulting (Beijing) Co., Ltd. to Acquire the Company's Shares

February 13, 2025

Announcement on Canceling Accounts for Idle Raised Funds

January 24, 2025

Announcement on the Results of Tender Offer by Shuangrun Zhengan Information Consulting (Beijing) Co., Ltd. and Resumption of Stock Trading

January 23, 2025

Announcement on Tender Offer Expiration and Suspension of Stock Trading of Shuangrun Zhengan Information Consulting (Beijing) Co., Ltd.

January 22, 2025

Announcement on Cancellation of Some Special Accounts for Raised Funds

January 17, 2025

The 3rd Indicative Announcement on Shuangrun Zheng'an Information Consulting (Beijing) Co., Ltd. Offering to Acquire the Company's Shares

January 13, 2025